Wuxi AppTec raises US$981 mn in Hong Kong offer amid growing appetite for Chinese biotech
Wuxi AppTec, Asia’s largest provider of contract pharmaceutical research, has raised HK$7.70 billion (US$981 million) through a sale of additional shares in Hong Kong as it rides the wave of…